To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene RASSF7TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
178 supporting clones for gene RASSF7 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BF116172 fibrotheoma, ovary .a 1 to 497 1 to 496   tiling clone, Submitted on the opposite strand 496/496
(100 %)
1 diff
(99.8 %id)
DB475407 hippocampus .a 139 to 611 1 to 473   tiling clone,   473/473
(100 %)
3 diff
(99.4 %id)
BM921990 pooled brain, lung, testis .a 351 to 1131 25 to 808       784/1031
(76 %)
23 diff
(97.8 %id)
BI772679 pooled lung and spleen .a 364 to 1052 32 to 717       686/717
(95 %)
10 diff
(98.7 %id)
TI_57183298   .a 364 to 1052 32 to 717       686/717
(95 %)
10 diff
(98.7 %id)
CR998570 T-Lymphocytes .a 366 to 1011 1 to 647   tiling clone,   647/649
(99 %)
3 diff
(99.6 %id)
CA488464   .a 371 to 1187 1 to 820       820/963
(85 %)
29 diff
(97.0 %id)
BE884853 leiomyosarcoma, uterus .a 376 to 866 1 to 499       499/501
(99 %)
14 diff
(97.3 %id)
BQ214796 melanotic melanoma, skin .a 784 to 1561 5 to 787   tiling clone,   783/886
(88 %)
21 diff
(97.7 %id)
BC106921 PCR rescued clones .b 1 to 1476 9 to 1484 exact tiling clone,   1476/1484
(99 %)
6 diff
(99.6 %id)
M91083 placenta .b 1 to 1530 9 to 1539 exact     1531/1539
(99 %)
11 diff
(99.3 %id)
NM_003475.3   .b 1 to 1536 1 to 1536 exact RefSeq, AAA   1536/1536
(100 %)
0 diff
(100 %id)
CR623626 Placenta Cot 25-normalized .b 34 to 1504 1 to 1471       1471/1471
(100 %)
1 diff
(100.0 %id)
AL552725 placenta, Placenta Cot 25-normalized .b 34 to 935 1 to 902   fully sequenced,   902/902
(100 %)
2 diff
(99.8 %id)
BM786215 stomach .b 620 to 1058 1 to 438       438/438
(100 %)
3 diff
(99.4 %id)
BX283283 endometrium, adenocarcinoma cell line, uterus .b 888 to 1407 1 to 520       520/520
(100 %)
1 diff
(99.9 %id)
BE515278 endometrium, adenocarcinoma cell line, uterus .b 889 to 1532 35 to 679   AAA   645/679
(94 %)
11 diff
(98.4 %id)
AL576053 placenta, Placenta Cot 25-normalized .b 905 to 1504 597 to 1   fully sequenced,   597/597
(100 %)
4 diff
(99.4 %id)
AI688198 colon .b 972 to 1537 562 to 1       562/563
(99 %)
16 diff
(97.2 %id)
BF438314 Prostate .b 981 to 1530 550 to 1       550/550
(100 %)
0 diff
(100 %id)
AW514706 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 985 to 1537 556 to 4   tiling clone,   553/640
(86 %)
10 diff
(98.5 %id)
BX447921 fetal liver, Liver .c 1 to 864 1 to 859   fully sequenced,   859/859
(100 %)
13 diff
(98.5 %id)
CR612580 fetal liver .c 2 to 1746 1 to 1745 P128A tiling clone,   1745/1745
(100 %)
1 diff
(100.0 %id)
BU168418 ductal carcinoma, cell line, Pancreas .c 53 to 915 1 to 878       878/1051
(83 %)
36 diff
(96.6 %id)
BQ899064 ductal carcinoma, cell line, Pancreas .c 53 to 870 1 to 822       822/872
(94 %)
11 diff
(98.8 %id)
BG255600 adenocarcinoma, cell line, Prostate .c 244 to 978 1 to 731       729/731
(99 %)
14 diff
(98.1 %id)
BG741624 skin .c 257 to 1039 1 to 809       807/811
(99 %)
38 diff
(95.4 %id)
BM769566 stomach .c 288 to 599 1 to 312       312/312
(100 %)
0 diff
(100 %id)
BM769594 stomach .c 288 to 846 1 to 560       560/560
(100 %)
1 diff
(99.9 %id)
CA454507   .c 293 to 1069 1 to 781       781/898
(86 %)
5 diff
(99.5 %id)
BM797672 Ascites, stomach .c 304 to 707 1 to 405       405/405
(100 %)
2 diff
(99.6 %id)
BM547304 ovary (pool of 3) .c 368 to 1102 1 to 736   tiling clone,   736/1179
(62 %)
11 diff
(99.1 %id)
C18512 placenta .c 396 to 827 1 to 427       427/427
(100 %)
9 diff
(97.9 %id)
CR980782 T-Lymphocytes .c 423 to 1067 1 to 645       645/645
(100 %)
1 diff
(99.9 %id)
BG742441 skin .c 521 to 1301 1 to 786       786/792
(99 %)
31 diff
(96.1 %id)
BM769192 stomach .c 557 to 847 1 to 291       291/291
(100 %)
0 diff
(100 %id)
CR990242 T-Lymphocytes .c 574 to 1009 1 to 436       436/436
(100 %)
1 diff
(99.8 %id)
BM554656 amelanotic melanoma, cell line, skin .c 618 to 1609 19 to 1016       998/1136
(87 %)
49 diff
(95.7 %id)
BM553755 amelanotic melanoma, cell line, skin .c 618 to 1090 20 to 493       474/505
(93 %)
8 diff
(98.5 %id)
BM912230 amelanotic melanoma, cell line, skin .c 618 to 1089 18 to 489       472/1236
(38 %)
13 diff
(99.0 %id)
BM559960 amelanotic melanoma, cell line, skin .c 618 to 1099 19 to 499       481/500
(96 %)
7 diff
(98.6 %id)
BM558704 amelanotic melanoma, cell line, skin .c 618 to 1393 21 to 796       776/1047
(74 %)
18 diff
(98.3 %id)
BM914907 amelanotic melanoma, cell line, skin .c 618 to 1338 18 to 739       722/1109
(65 %)
17 diff
(98.5 %id)
BM914928 amelanotic melanoma, cell line, skin .c 618 to 1278 18 to 681       664/1048
(63 %)
18 diff
(98.3 %id)
BM009153 amelanotic melanoma, cell line, skin .c 622 to 1194 1 to 575       575/576
(99 %)
11 diff
(98.1 %id)
BM010207 amelanotic melanoma, cell line, skin .c 622 to 1179 1 to 559       559/906
(61 %)
20 diff
(97.8 %id)
TI_59383868   .c 623 to 1194 62 to 635       574/575
(99 %)
10 diff
(98.3 %id)
TI_59385010   .c 623 to 1179 97 to 654       558/905
(61 %)
19 diff
(98.0 %id)
BM808267 amelanotic melanoma, cell line, skin .c 624 to 1442 1 to 824       824/1076
(76 %)
22 diff
(98.0 %id)
BM915543 amelanotic melanoma, cell line, skin .c 624 to 1100 1 to 484       484/746
(64 %)
7 diff
(99.1 %id)
AV694247 hepatocellular carcinoma .c 723 to 1539 1 to 811       811/815
(99 %)
40 diff
(95.1 %id)
CR995266 T-Lymphocytes .c 744 to 1184 1 to 442       442/446
(99 %)
2 diff
(99.6 %id)
AA485171 germinal center B cell .c 812 to 1161 10 to 355       346/356
(97 %)
7 diff
(98.1 %id)
BX447920 fetal liver, Liver .c 834 to 1740 905 to 7   fully sequenced,   899/905
(99 %)
8 diff
(99.2 %id)
TI_57146232   .c 908 to 1577 64 to 747       684/806
(84 %)
24 diff
(97.1 %id)
BI759089 pooled colon, kidney, stomach .c 914 to 1577 1 to 677       677/736
(91 %)
18 diff
(97.6 %id)
BQ083740 stomach .c 1007 to 1277 1 to 271       271/271
(100 %)
1 diff
(99.7 %id)
BQ084472 stomach .c 1007 to 1298 1 to 292       292/292
(100 %)
0 diff
(100 %id)
BG256945 embryonal carcinoma, cell line, testis .c 1054 to 1183 1 to 130       130/130
(100 %)
0 diff
(100 %id)
CR613045 Placenta Cot 25-normalized .d 1 to 1613 1 to 1613 P89A tiling clone,   1613/1613
(100 %)
1 diff
(100.0 %id)
CR591016 Placenta Cot 25-normalized .d 3 to 1707 1 to 1705 P89A     1705/1705
(100 %)
1 diff
(100.0 %id)
AL549033 placenta, Placenta Cot 25-normalized .d 3 to 852 1 to 849   fully sequenced,   849/849
(100 %)
6 diff
(99.3 %id)
CR618937 Placenta Cot 25-normalized .d 16 to 1712 1 to 1697 P89A     1697/1697
(100 %)
1 diff
(100.0 %id)
BI825060 pooled brain, lung, testis .d 16 to 554 1 to 542       542/685
(79 %)
6 diff
(99.2 %id)
TI_57201573   .d 16 to 554 1 to 542       542/685
(79 %)
6 diff
(99.2 %id)
NM_001143993.1   .d 16 to 1743 1 to 1728   RefSeq, AAA   1728/1728
(100 %)
0 diff
(100 %id)
AL544102 placenta, Placenta Cot 25-normalized .d 17 to 1018 1 to 987   fully sequenced,   987/987
(100 %)
6 diff
(99.4 %id)
AL543829 placenta, Placenta Cot 25-normalized .d 19 to 834 20 to 834   fully sequenced,   815/834
(97 %)
34 diff
(96.0 %id)
TI_57198691   .d 22 to 516 65 to 559       495/561
(88 %)
7 diff
(98.8 %id)
BI822596 pooled brain, lung, testis .d 23 to 516 1 to 494       494/496
(99 %)
1 diff
(99.8 %id)
TI_57234329   .d 23 to 817 30 to 820       791/821
(96 %)
17 diff
(98.0 %id)
BU187732 eye, retinoblastoma .d 25 to 908 1 to 892       892/917
(97 %)
32 diff
(96.6 %id)
CR604720 Placenta Cot 25-normalized .d 28 to 1714 1 to 1687 P89A     1687/1687
(100 %)
1 diff
(100.0 %id)
AL549374 placenta, Placenta Cot 25-normalized .d 28 to 1016 1 to 975   fully sequenced,   975/975
(100 %)
13 diff
(98.7 %id)
BI907597 leukocyte .d 28 to 817 1 to 786       786/787
(99 %)
11 diff
(98.7 %id)
BG029534 breast, mammary adenocarcinoma, cell line .d 29 to 795 10 to 769       760/990
(76 %)
23 diff
(97.7 %id)
BM913577 amelanotic melanoma, cell line, skin .d 29 to 583 21 to 576       556/1134
(49 %)
14 diff
(98.8 %id)
TI_59384906   .d 29 to 569 97 to 637       541/541
(100 %)
1 diff
(99.9 %id)
BM010109 amelanotic melanoma, cell line, skin .d 30 to 569 1 to 540       540/540
(100 %)
1 diff
(99.9 %id)
CR979617 T-Lymphocytes .d 31 to 831 1 to 801   tiling clone,   801/803
(99 %)
1 diff
(99.9 %id)
TI_57232316   .d 33 to 817 21 to 793       773/796
(97 %)
23 diff
(97.2 %id)
CX166283 human embryonic stem cells differentiated toan early endodermal cell type .d 35 to 826 1 to 792       792/792
(100 %)
1 diff
(99.9 %id)
BF983054 duodenal adenocarcinoma, cell line, small intestine .d 38 to 802 1 to 745       745/919
(81 %)
64 diff
(93.1 %id)
BI906386 leukocyte .d 38 to 817 1 to 768       768/771
(99 %)
19 diff
(97.6 %id)
BX341978   .d 41 to 1022 1 to 976       976/1004
(97 %)
21 diff
(98.0 %id)
BI523944 pooled lung and spleen .d 41 to 676 1 to 636       636/636
(100 %)
0 diff
(100 %id)
TI_44159015   .d 41 to 702 71 to 732       662/734
(90 %)
7 diff
(99.1 %id)
CR611851 HeLa cells Cot 25-normalized .d 44 to 1731 1 to 1688 P89A tiling clone,   1688/1688
(100 %)
1 diff
(100.0 %id)
TI_57199333   .d 44 to 560 60 to 576       517/576
(89 %)
6 diff
(99.0 %id)
AL555936 placenta .d 45 to 908 1 to 861       861/1131
(76 %)
10 diff
(99.2 %id)
BG480061 choriocarcinoma, placenta .d 45 to 878 1 to 831       831/836
(99 %)
23 diff
(97.3 %id)
BM549955 leukocyte .d 45 to 701 1 to 664       664/1488
(44 %)
21 diff
(98.6 %id)
BM928217 brain .d 47 to 908 1 to 875       875/1086
(80 %)
28 diff
(97.5 %id)
CA454383   .d 47 to 575 1 to 528       528/566
(93 %)
7 diff
(98.8 %id)
BX361879   .d 48 to 1024 1 to 967       967/1004
(96 %)
23 diff
(97.8 %id)
BI821641 pooled brain, lung, testis .d 50 to 560 1 to 511       511/511
(100 %)
0 diff
(100 %id)
BI761081 pooled colon, kidney, stomach .d 50 to 880 1 to 837       837/839
(99 %)
18 diff
(97.9 %id)
TI_57146767   .d 50 to 880 31 to 867       837/869
(96 %)
24 diff
(97.3 %id)
BQ686750 ductal carcinoma, cell line, Pancreas .d 53 to 494 22 to 463       442/1038
(42 %)
16 diff
(98.5 %id)
CN261306 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 57 to 407 8 to 357       350/357
(98 %)
8 diff
(97.8 %id)
BE901501 choriocarcinoma, placenta .d 62 to 795 1 to 714       714/922
(77 %)
19 diff
(98.0 %id)
BI766050 pooled lung and spleen .d 62 to 676 26 to 640       615/640
(96 %)
0 diff
(100 %id)
TI_57177968   .d 62 to 880 26 to 844       819/845
(96 %)
8 diff
(99.1 %id)
BG999819 head_normal .d 63 to 245 185 to 3       183/185
(98 %)
1 diff
(99.5 %id)
BU168276 hepatocellular carcinoma, cell line, Liver .d 63 to 566 1 to 504       504/1269
(39 %)
15 diff
(98.9 %id)
BQ938659 epidermoid carcinoma, cell line, lung .d 64 to 641 1 to 578       578/1071
(53 %)
15 diff
(98.6 %id)
AW402263 lymph .d 66 to 556 8 to 498       491/498
(98 %)
1 diff
(99.8 %id)
TI_154138596   .d 66 to 575 81 to 590       510/511
(99 %)
2 diff
(99.7 %id)
BF683624 leiomyosarcoma cell line, uterus .d 67 to 774 1 to 712       712/1049
(67 %)
34 diff
(96.8 %id)
BF973306 leiomyosarcoma cell line, uterus .d 67 to 666 1 to 604       604/1063
(56 %)
19 diff
(98.3 %id)
BE266640 lung, small cell carcinoma .d 71 to 749 1 to 674       674/723
(93 %)
21 diff
(97.1 %id)
AL570157 placenta, Placenta Cot 25-normalized .d 806 to 1521 817 to 92   fully sequenced,   726/817
(88 %)
6 diff
(99.3 %id)
AL573382 placenta, Placenta Cot 25-normalized .d 822 to 1707 885 to 1   fully sequenced,   885/885
(100 %)
9 diff
(99.0 %id)
BI524688 pooled lung and spleen .d 845 to 1690 845 to 2       844/845
(99 %)
4 diff
(99.6 %id)
TI_44159016   .d 845 to 1690 845 to 2       844/845
(99 %)
4 diff
(99.6 %id)
AL578305 placenta .d 905 to 1731 826 to 1       826/1124
(73 %)
3 diff
(99.8 %id)
AL549373 placenta, Placenta Cot 25-normalized .d 986 to 1714 724 to 1   fully sequenced,   724/724
(100 %)
19 diff
(97.4 %id)
AL570411 placenta, Placenta Cot 25-normalized .d 988 to 1712 722 to 1   fully sequenced,   722/722
(100 %)
8 diff
(98.9 %id)
TI_57178515   .d 1011 to 1611 29 to 628       600/640
(93 %)
6 diff
(99.1 %id)
BM726453 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 1035 to 1685 1 to 651       651/651
(100 %)
0 diff
(100 %id)
CB306823 Human Lung Epithelial cells, lung .d 1065 to 1737 693 to 19   AAA   675/675
(100 %)
2 diff
(99.8 %id)
CA315057 Human Lung Epithelial cells, lung .d 1065 to 1743 697 to 19   AAA   679/679
(100 %)
0 diff
(100 %id)
CA424759 cell lines, Chondrosarcoma .d 1066 to 1737 691 to 19   AAA   673/673
(100 %)
1 diff
(99.9 %id)
BQ773922 Chondrosarcoma Grade II, Left Pelvis .d 1104 to 1743 656 to 19   AAA   638/638
(100 %)
2 diff
(99.7 %id)
AI858428 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 1114 to 1738 624 to 2       623/626
(99 %)
0 diff
(100 %id)
CV569232 cornea, eye .d 1134 to 1734 1 to 603       603/603
(100 %)
2 diff
(99.7 %id)
TI_154135757   .d 1138 to 1737 702 to 100   AAA   603/941
(64 %)
13 diff
(98.7 %id)
BG164888 hypernephroma, cell line, Kidney .d 1142 to 1737 1 to 594   AAA   594/594
(100 %)
2 diff
(99.7 %id)
BI819754 pooled brain, lung, testis .d 1144 to 1742 1 to 600       600/634
(94 %)
2 diff
(99.7 %id)
TI_57202993   .d 1144 to 1742 59 to 658       600/963
(62 %)
2 diff
(99.8 %id)
AI619490 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .d 1145 to 1737 621 to 31   AAA   591/591
(100 %)
15 diff
(97.5 %id)
AW008257 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .d 1188 to 1737 578 to 29   AAA   550/551
(99 %)
28 diff
(95.0 %id)
CA312964 Human Lung Epithelial cells, lung .d 1217 to 1743 547 to 19   AAA   529/529
(100 %)
5 diff
(99.1 %id)
BX331037   .d 1230 to 1738 508 to 1       508/723
(70 %)
40 diff
(94.5 %id)
AW044564 pooled .d 1252 to 1744 493 to 1   tiling clone,   493/497
(99 %)
2 diff
(99.6 %id)
TI_157599704   .e 1 to 401 459 to 59   tiling clone,   401/1003
(39 %)
0 diff
(100 %id)
BI818529 pooled brain, lung, testis .e 27 to 389 1 to 365       365/369
(98 %)
10 diff
(97.3 %id)
AI148716 placenta .e 37 to 378 342 to 1       342/342
(100 %)
0 diff
(100 %id)
AW014588   .e 395 to 928 1 to 534   tiling clone, Submitted on the opposite strand 534/534
(100 %)
1 diff
(99.9 %id)
BC106922 PCR rescued clones .e 435 to 1827 9 to 1401 P89A tiling clone,   1393/1401
(99 %)
7 diff
(99.6 %id)
NM_001143994.1   .e 435 to 1887 1 to 1453 exact RefSeq, AAA   1453/1453
(100 %)
0 diff
(100 %id)
CR997713 T-Lymphocytes .e 701 to 1434 1 to 735       735/735
(100 %)
2 diff
(99.8 %id)
BQ323633 colon_ins .e 1127 to 1497 14 to 384       371/390
(95 %)
10 diff
(97.5 %id)
AW001214 colon, colonic mucosa from 3 patients with Crohn'sdisease .e 1150 to 1888 742 to 3   tiling clone,   740/752
(98 %)
23 diff
(97.0 %id)
BE620307 large cell carcinoma, undifferentiated, lung .e 1312 to 1884 1 to 572       572/572
(100 %)
1 diff
(99.9 %id)
AI915066 ovary, tumor, 5 pooled (see description) .e 1370 to 1881 511 to 1       511/511
(100 %)
3 diff
(99.5 %id)
AA838541 epithelium (cell line), Prostate .e 1413 to 1881 469 to 1       469/469
(100 %)
8 diff
(98.3 %id)
AI141014 B-cell, chronic lymphotic leukemia .e 1413 to 1882 471 to 2       470/471
(99 %)
0 diff
(100 %id)
AI382210 B-cell, chronic lymphotic leukemia .e 1413 to 1882 470 to 1       470/470
(100 %)
4 diff
(99.2 %id)
AW514693 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .e 1413 to 1502 91 to 2       90/91
(98 %)
0 diff
(100 %id)
DB544230 hippocampus .e 1416 to 1881 1 to 467     Submitted on the opposite strand 467/467
(100 %)
3 diff
(99.4 %id)
AA515218 colon .e 1434 to 1887 454 to 1       454/454
(100 %)
5 diff
(98.9 %id)
AI288589 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 1434 to 1887 454 to 1       454/455
(99 %)
4 diff
(99.2 %id)
AI272942 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 1443 to 1887 445 to 1       445/445
(100 %)
3 diff
(99.4 %id)
CB048775 Prostate .e 1448 to 1881 1 to 434   fully sequenced, AAA   434/434
(100 %)
4 diff
(99.1 %id)
BM825465 Ascites, stomach .e 1454 to 1880 1 to 427       427/427
(100 %)
0 diff
(100 %id)
AI826272 normal prostate, Prostate .e 1466 to 1886 444 to 24   AAA   421/421
(100 %)
25 diff
(94.1 %id)
AI693518 pooled .e 1475 to 1882 410 to 3       408/410
(99 %)
0 diff
(100 %id)
BP388157 pancreatic islet .e 1488 to 1883 1 to 396     Submitted on the opposite strand 396/400
(99 %)
2 diff
(99.5 %id)
CA442141 lung, Lung Focal Fibrosis .e 1488 to 1887 420 to 19   AAA   402/409
(98 %)
2 diff
(99.6 %id)
CB048774 Prostate .e 1493 to 1881 411 to 23   fully sequenced, AAA   389/389
(100 %)
0 diff
(100 %id)
BM854646 stomach .e 1506 to 1881 1 to 376   AAA   376/376
(100 %)
0 diff
(100 %id)
AI129723 uterus .e 1519 to 1883 373 to 10       364/377
(96 %)
0 diff
(100 %id)
AI684404 pooled .e 1524 to 1882 360 to 1       360/360
(100 %)
1 diff
(99.8 %id)
AA970526 2 pooled tumors (clear cell type), Kidney .e 1530 to 1887 357 to 1       357/357
(100 %)
1 diff
(99.8 %id)
AW268245 invasive adenocarcinoma, lung .e 1538 to 1750 1 to 213     Submitted on the opposite strand 213/213
(100 %)
6 diff
(97.2 %id)
AW268175 invasive adenocarcinoma, lung .e 1543 to 1884 35 to 376   AAA Submitted on the opposite strand 342/376
(90 %)
6 diff
(98.5 %id)
BP390784 pancreatic islet .e 1572 to 1882 1 to 311     Submitted on the opposite strand 311/311
(100 %)
0 diff
(100 %id)
AI659747 Prostate .e 1587 to 1887 316 to 17   AAA   300/300
(100 %)
3 diff
(99.0 %id)
AA612760 colon, colon tumor RER+ .e 1591 to 1879 301 to 14       288/301
(95 %)
0 diff
(100 %id)
DB531859 hippocampus .e 1620 to 1882 1 to 263     Submitted on the opposite strand 263/265
(99 %)
13 diff
(95.1 %id)
AI343254 colon, colon tumor, RER+ .e 1666 to 1887 237 to 16   AAA   222/222
(100 %)
4 diff
(98.2 %id)
AI933955 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .e 1687 to 1881 195 to 1       195/195
(100 %)
2 diff
(99.0 %id)
AA603721 germ cell tumor .e 1711 to 1883 209 to 37   AAA   173/173
(100 %)
1 diff
(99.5 %id)
DB465297 hippocampus .f 1 to 425 1 to 424       424/424
(100 %)
15 diff
(96.5 %id)
CR980434 T-Lymphocytes .f 6 to 669 1 to 664   tiling clone,   664/664
(100 %)
1 diff
(99.9 %id)
CR980111 T-Lymphocytes .f 6 to 658 1 to 654   tiling clone,   654/659
(99 %)
4 diff
(99.4 %id)
CR974964 T-Lymphocytes .f 6 to 673 1 to 671   tiling clone,   671/671
(100 %)
5 diff
(99.3 %id)
CN261305 embryonic stem cells, DMSO-treated H9 cellline .f 28 to 504 1 to 477       477/477
(100 %)
0 diff
(100 %id)
CR595567 fetal brain .g 1 to 1679 1 to 1679 exact tiling clone,   1679/1679
(100 %)
1 diff
(100.0 %id)
AL535761 brain, fetal brain .g 1 to 918 1 to 916 exact tiling clone, fully sequenced,   916/916
(100 %)
4 diff
(99.6 %id)
AL566039 brain, fetal brain .g 857 to 1665 819 to 13   fully sequenced,   807/819
(98 %)
1 diff
(99.9 %id)
BM741368 stomach .h-u 1 to 571 1 to 571 exact tiling clone,   571/571
(100 %)
0 diff
(100 %id)
TI_159714759   .h-u 68 to 903 914 to 83   AAA   832/994
(83 %)
14 diff
(98.6 %id)
BM693778 eye, lens .h-u 80 to 235 1 to 156       156/156
(100 %)
1 diff
(99.4 %id)
AI660858 colon, colonic mucosa from 3 patients with Crohn'sdisease .h-u 83 to 906 842 to 16   tiling clone, AAA   827/827
(100 %)
27 diff
(96.8 %id)
CD671911 eye, Iris .h-u 165 to 802 1 to 638       638/638
(100 %)
2 diff
(99.7 %id)
BI769163 pooled lung and spleen .h-u 177 to 777 1 to 600       600/612
(98 %)
6 diff
(99.1 %id)
BU738218 eye, lens .h-u 288 to 903 634 to 19   tiling clone, AAA   616/621
(99 %)
1 diff
(99.9 %id)
AI935001 pooled Gene RASSF7, variant not shown         Suspected internal deletion, this clone was ignored    
AW573256 pooled Gene RASSF7, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI